Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karen M. Kumor is active.

Publication


Featured researches published by Karen M. Kumor.


Psychopharmacology | 1989

Placebo responses to cocaine administration in humans: effects of prior administrations and verbal instructions

Carles Muntaner; Nicola G. Cascella; Karen M. Kumor; Craig T. Nagoshi; Ron Herning; Jerome H. Jaffe

Subjective and physiological responses of eight male cocaine-using research volunteers were studied after a double-blind saline infusion (placebo) was given when subjects were instructed that a cocaine infusion might be given. Cardiovascular and subjective responses to placebo were similar in pattern and direction, though of lesser magnitude, than after a 40 mg cocaine infusion. These placebo responses were compared to responses after an earlier saline infusion condition in which subjects were instructed prior to the infusion that they would receive saline (instructed placebo). The design was thus meant to test for the effects of instructions on placebo responses to cocaine. Heart rates at baseline (pre-infusion) were significantly higher in the placebo than in the instructed placebo condition. Similar trends were found for elevated baseline placebo responses on two subjective effects measures. A comparison with an initial placebo session prior to the placebo and instructed placebo conditions described above provided evidence for conditioning of placebo responses on diastolic blood pressure and heart rate. The present results suggest that verbal instructions, as well as conditioning in the laboratory, could contribute to the observed placebo responses to cocaine infusions.


Psychopharmacology | 1991

Effects of nifedipine pretreatment on subjective and cardiovascular responses to intravenous cocaine in humans

Carles Muntaner; Karen M. Kumor; Craig T. Nagoshi; Jerome H. Jaffe

The effects of oral nifedipine pretreatment on subjective and cardiovascular responses to intravenous cocaine infusions were studied in cocaine-using volunteers. Nifedipine, 10 mg or placebo, was administered 20–25 min before placebo, 20 mg, or 40 mg cocaine, using a repeated measures randomized double-blind design. The variables measured were self-reported subjective effects, general behavior rated by two observers, blood pressure and heart rate. Cocaine produced the expected dose-related effects on subjective and cardiovascular measures. Nifedipine pretreatment attenuated some subjective effects of cocaine. Nifedipine directly reduced blood pressure but did not antagonize the effects of cocaine on blood pressure. These findings suggest that dihydropyridine calcium channel modulators may be useful compounds in the clinical management of cocaine users.


Journal of Substance Abuse | 1994

Impulsiveness and subjective effects of intravenous cocaine administration in the laboratory

Nicola G. Cascella; Craig T. Nagoshi; Charles Muntaner; Daniel Walter; Charles A. Haertzen; Karen M. Kumor

Cardiovascular and subjective responses to placebo and 40-mg intravenous (iv) cocaine injections were measured in 29 male iv cocaine users: most subjects received each of these injections on two separate occasions. Most of the subjects also completed various measures of psychopathology and personality. Although the small sample size made any conclusions tentative, an expected significant association between impulsivity and subjective euphoria following 40-mg cocaine administration was obtained, whereas associations of personality measures with cardiovascular responses to cocaine administration were inconsistent.


Pharmacology, Biochemistry and Behavior | 1989

Intravenous cocaine infusions in humans: Dose responsivity and correlations of cardiovascular vs. subjective effects

Carles Muntaner; Karen M. Kumor; Craig T. Nagoshi; Jerome H. Jaffe

Eight experienced IV cocaine users were intravenously administered 0, 10, 20, and 40 mg of cocaine hydrochloride on separate days in a pseudo-randomized ascending dose series, such that the 20 mg dose always preceded the 40 mg dose. They were subsequently administered 0, 20, and 40 mg of cocaine in a fully randomized presentation order. Cardiovascular effects of cocaine were significantly different from placebo for the 20 mg, but not the 10 mg dose, in contrast to subjective responses which differed from placebo for the 10 mg dose. Cardiovascular and subjective effects of cocaine did not differ between the 20 and 40 mg dose conditions for the pseudo-randomized trials, but did differ in the fully randomized trials. This lack of difference in responsivity between the 20 and 40 mg dose in the earlier trials may possibly have been due to contrast effects. Cardiovascular responses were not consistently correlated with subjective responses, either within a cocaine dose condition or across doses.


Biological Psychiatry | 1989

Cardiovascular responses to cocaine placebo in humans: A preliminary report

Nicola G. Cascella; Carles Muntaner; Karen M. Kumor; Craig T. Nagoshi; Jerome H. Jaffe; Michael A. Sherer

Cardiovascular responses after placebo-cocaine injections were in the same direction as the effect of cocaine iv in 22 male volunteers. Subjects received iv placebo in a room where they had been given repeated doses of iv cocaine. The placebo response consisted of an increase from baseline values of systolic and diastolic blood pressure and pulse rate. The control group, 8 subjects, which was not exposed to a conditioning phase, showed a smaller increase in the pulse rate and systolic blood pressure after the placebo injection. The results, in accordance with animal literature, suggest the existence of cocaine-conditioned effects in humans.


Archives of General Psychiatry | 1988

Suspiciousness Induced by Four-Hour Intravenous Infusions of Cocaine: Preliminary Findings

Michael A. Sherer; Karen M. Kumor; Edward J. Cone; Jerome H. Jaffe


The Lancet | 1986

HALOPERIDOL-INDUCED DYSTONIA IN COCAINE ADDICTS

Karen M. Kumor; Michael A. Sherer; Jerome H. Jaffe


Addiction | 1992

Test-retest stability of cardiovascular and subjective responses to intravenous cocaine in humans

Craig T. Nagoshi; Karen M. Kumor; Carles Muntaner


Archive | 1989

Use of calcium channel blocker to prevent cocaine induced craving and reinforcement

Jerome H. Jaffe; Karen M. Kumor


Archive | 1988

Effects of nifedipine (a Ca++ modulator) pre-treatment on cardiovascular and subjective responses to intravenous cocaine administration in humans

Carles Muntaner; Karen M. Kumor; Craig T. Nagoshi; Jerome H. Jaffe

Collaboration


Dive into the Karen M. Kumor's collaboration.

Top Co-Authors

Avatar

Jerome H. Jaffe

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael A. Sherer

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Charles A. Haertzen

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Charles Muntaner

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Daniel Walter

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Edward J. Cone

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

R. Herning

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge